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Abstract
Our laboratory has developed a recombined porcine-derived mixed bacterial culture (RPCF) isolated from the ceca of a 
healthy, pathogen-free pig and have maintained it at steady state in a continuous-flow chemostat. The culture has been 
shown to protect neonatal and weaned pigs from infection and disease caused by Salmonella and E. coli. However, the 
mechanism of action of the protection from pathogens observed with the RPCF culture remains unclear.  In the present 
study, 40 piglets were delivered by caesarian section and reared under gnotobiotic conditions.  Piglets were either given 
RPCF within 1 hr after birth or were given sterile media.  At times 0, 8, 24, 48, and 72 hr post-birth, piglets were euthanized 
and samples of spleen taken.  Splenic cells from individual piglets were isolated and cultured with or without concanav-
alin A (conA).  Splenic cells from RPCF-treated piglets had increased levels of IL-1β, IFN-γ, IL-18, and IL-10 at 8 hr after 
birth compared to control piglets as measured by porcine cytokine ELISA. The increased levels of cytokines produced by 
RPCF-treated piglet splenocytes then declined over time, returning to levels observed in control pigs, or in some instances, 
below control levels.  These results suggest that RPCF may act as a modulator for certain aspects of innate immune devel-
opment.
Introduction
Our laboratory has developed a recombined, porcine-derived continuous-flow culture of mixed commensal 
bacteria (Gram-positive obligate anaerobes), designated as RPCF.  RPCF has eliminated multiple strains of Esche-
richia coli and Salmonella from chemostats during in vitro challenge (1).  When piglets are orally dosed with RPCF 
within 24 h of birth, the treated piglets have reduced colonization, shedding, and disease from E. coli and Sal-
monella following laboratory challenge with virulent strains of these organisms (2,3).  Furthermore, under field 
trial conditions, treatment of piglets at birth decreased mortality and medication costs associated with entero-
toxigenic strains of E. coli (4).  The mechanism of protection is unknown, but the authors speculate that it could 
be exclusion of pathogens by competition for attachment sites, receptors, or nutrition; production of bactericidal 
compounds such as bacteriocins; modulation and enhancement of immune function; or all of the above.  It is 
a known fact that commensal bacteria play an important role in the development of innate immune responses.  
The objective of the present study was to determine if RPCF could affect innate immune response in gnotobiotic 
piglets.   
Materials and Methods
Forty piglets were delivered by caesarian section and reared under gnotobiotic conditions.  Piglets were either 
given RPCF within 1 h after birth or were given sterile media.  At times 0, 8, 24, 48, and 72 h post-birth, 4 piglets 
from each group (total of 8 per time frame) were euthanized and samples of spleen taken.  Splenic cells from RP-
CF-treated piglets were isolated and cultured with or without concanavalin A (ConA) and analyzed by porcine 
cytokine ELISA for concentrations of IL-1β, IFN-γ, IL-4, IL-10, and IL-18.
Results and Conclusions
Splenic cells from RPCF-treated piglets had increased levels of IL-1β, IFN-γ, IL-10, and IL-18 at 8 h after birth 
compared to control piglets.  The increased levels of cytokines produced by RPCF-treated splenocytes then 
declined over time, returning to levels observed in control pigs, or in some instances, below control levels.  We 
conclude that RPCF can affect immune function in neonates and speculate that early innate responses observed 
herein may positively impact acquired immune responses later.
Discussion
These results suggest that RPCF may act as a modulator for certain aspects of innate immune function.  If so, 
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RPCF could be used to “prime the pump” of the immune system which could induce earlier development of the 
innate system in neonates.  In neonatal mammals, it appears that the immune system becomes “tolerant” of the 
commensal flora as it is exposed to them, eventually leading to a “non-response” to these bacterial species (5,6,7,8). 
Although there is a response to these organisms, this response is not detrimental to the host, keeping the normal 
flora relegated to their normal niche within or on the host. In this way, the host does not continue to respond to 
the normal flora in a costly way, saving a robust response for pathogens the host encounters. Failure of the im-
mune system to tolerate the commensal flora can lead to inflammatory disease in the host (5). Indeed, in swine, 
Lactobacillus species have been shown to enhance the immune response of pigs to an E. coli challenge, inducing T 
cell differentiation and enhanced cytokine expression (9). IL-1β, IFN-γ and IL-18 are considered pro-inflamma-
tory cytokines, aiding in the production of an immune response to non-self antigens. These cytokines would also 
be considered to be indicators of an innate immune response, the first line of defense of the host, leading to the 
production of the acquired immune response. It is unclear, however, if the production of these cytokines and the 
subsequent induction of the innate immune response are responsible for the protective effects of the RPCF culture, 
or if this response is part of the tolerance process. The induction of IL-10 production would indicate an attempt 
to modulate the response to the microflora, and perhaps an indication of the beginning of the tolerance process. 
Further studies would need to be specifically targeted to the tolerance process to flesh out the response, perhaps 
covering longer periods of time after birth.
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